ARMO Biosciences (ARMO) – SanaCurrents Case Study
ARMO Biosciences (ARMO) listed in January 2018 at $17 per [...]
ARMO Biosciences (ARMO) listed in January 2018 at $17 per [...]
Eiger Biopharmaceuticals (NASDAQ:EIGR), a company developing treatment for rare diseases, [...]
MyoKardia (NASDAQ:MYOK), a leading precision cardiovascular medicine company, reported good [...]
Dynavax's (NASDAQ:DVAX) BLA application for its Hepatitis B vaccine first [...]
California-based company Zogenix (NASDAQ:ZGNX) observed the drug fenfluramine, which had [...]